84 related articles for article (PubMed ID: 9507122)
21. Activity-linked alterations in cholecystokininB receptor messenger RNA levels in magnocellular hypothalamic neurones by food and water deprivation in the rat.
O'Shea RD; Gundlach AL
Neurosci Lett; 1995 Jul; 194(3):189-92. PubMed ID: 7478235
[TBL] [Abstract][Full Text] [Related]
22. Depolarizing action of cholecystokinin on rat supraoptic neurones in vitro.
Jarvis CR; Bourque CW; Renaud LP
J Physiol; 1992 Dec; 458():621-32. PubMed ID: 1302281
[TBL] [Abstract][Full Text] [Related]
23. An autoradiographic study of [3H]AMPA receptor binding and in situ hybridization of AMPA sensitive glutamate receptor A (GluR-A) subunits following morphine withdrawal in the rat brain.
Jang CG; Rockhold RW; Ho IK
Brain Res Bull; 2000 Jun; 52(3):217-21. PubMed ID: 10822164
[TBL] [Abstract][Full Text] [Related]
24. Cholecystokinin gene expression in rat amygdaloid neurons: normal distribution and effect of morphine tolerance.
Pu S; Zhuang H; Lu Z; Wu X; Han J
Brain Res Mol Brain Res; 1994 Feb; 21(3-4):183-9. PubMed ID: 8170343
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of oxytocin release within the supraoptic nucleus and into blood by CCK-8.
Neumann I; Landgraf R; Takahashi Y; Pittman QJ; Russell JA
Am J Physiol; 1994 Dec; 267(6 Pt 2):R1626-31. PubMed ID: 7810774
[TBL] [Abstract][Full Text] [Related]
26. Chronic morphine treatment inhibits oxytocin release from the supraoptic nucleus slices of rats.
Li J; You Z; Chen Z; Song C; Lu C
Neurosci Lett; 2001 Mar; 300(1):54-8. PubMed ID: 11172938
[TBL] [Abstract][Full Text] [Related]
27. Chronic morphine treatment inhibits oxytocin synthesis in rats.
You ZD; Li JH; Song CY; Wang CH; Lu CL
Neuroreport; 2000 Sep; 11(14):3113-6. PubMed ID: 11043533
[TBL] [Abstract][Full Text] [Related]
28. [Interactions between central opioidergic and cholecystokininergic systems in rats: possible significance for the development of of opioid tolerance].
Benoliel JJ; Becker C; Mauborgne A; Bourgoin S; Hamon M; Cesselin F
Bull Acad Natl Med; 1998; 182(2):311-24. PubMed ID: 9648346
[TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin (CCK)-like material and CCK mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment.
Pohl M; Collin E; Benoliel JJ; Bourgoin S; Cesselin F; Hamon M
Neuropeptides; 1992 Mar; 21(3):193-200. PubMed ID: 1630603
[TBL] [Abstract][Full Text] [Related]
30. Binding of 125I-cholecystokinin-octapeptide in the paraventricular but not the supraoptic nucleus is increased by ovariectomy.
Akesson TR; Micevych PE
Brain Res; 1986 Oct; 385(1):165-8. PubMed ID: 3768715
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of magnocellular vasopressin mRNA in rats with deoxycorticosterone-acetate induced salt appetite.
Grillo CA; Saravia F; Ferrini M; Piroli G; Roig P; García SI; de Kloet ER; De Nicola AF
Neuroendocrinology; 1998 Aug; 68(2):105-15. PubMed ID: 9705577
[TBL] [Abstract][Full Text] [Related]
32. Morphine withdrawal increases intrinsic excitability of oxytocin neurons in morphine-dependent rats.
Brown CH; Stern JE; Jackson KL; Bull PM; Leng G; Russell JA
Eur J Neurosci; 2005 Jan; 21(2):501-12. PubMed ID: 15673449
[TBL] [Abstract][Full Text] [Related]
33. Rapid but transient increases in cholecystokinin mRNA levels in cerebral cortex following amygdaloid-kindled seizures in the rat.
Burazin TC; Gundlach AL
Neurosci Lett; 1996 May; 209(1):65-8. PubMed ID: 8734911
[TBL] [Abstract][Full Text] [Related]
34. Differential kinetics of oxytocin and vasopressin heteronuclear RNA expression in the rat supraoptic nucleus in response to chronic salt loading in vivo.
Yue C; Mutsuga N; Sugimura Y; Verbalis J; Gainer H
J Neuroendocrinol; 2008 Feb; 20(2):227-32. PubMed ID: 18088359
[TBL] [Abstract][Full Text] [Related]
35. Extracellular cholecystokinin levels in the rat spinal cord following chronic morphine exposure: an in vivo microdialysis study.
Lucas GA; Hoffmann O; Alster P; Wiesenfeld-Hallin Z
Brain Res; 1999 Mar; 821(1):79-86. PubMed ID: 10064790
[TBL] [Abstract][Full Text] [Related]
36. Development of an excitatory kisspeptin projection to the oxytocin system in late pregnancy.
Seymour AJ; Scott V; Augustine RA; Bouwer GT; Campbell RE; Brown CH
J Physiol; 2017 Feb; 595(3):825-838. PubMed ID: 27589336
[TBL] [Abstract][Full Text] [Related]
37. Reversal of tolerance to morphine but no potentiation of morphine-induced analgesia by antiserum against cholecystokinin octapeptide.
Ding XZ; Fan SG; Zhou JP; Han JS
Neuropharmacology; 1986 Oct; 25(10):1155-60. PubMed ID: 3491337
[TBL] [Abstract][Full Text] [Related]
38. Chronic intracerebroventricular morphine and lactation in rats: dependence and tolerance in relation to oxytocin neurones.
Rayner VC; Robinson IC; Russell JA
J Physiol; 1988 Feb; 396():319-47. PubMed ID: 3411499
[TBL] [Abstract][Full Text] [Related]
39. Effects of CCK-8 on the reinstatement of morphine-induced CPP and expression of behavioral sensitization in rats.
Wen D; Zang G; Sun D; Yang S; Yu F; Li S; Ma C; Cong B
Neuroscience; 2013 May; 238():230-41. PubMed ID: 23466811
[TBL] [Abstract][Full Text] [Related]
40. Cholecystokinin receptor binding in morphine analgesia: tolerance, withdrawal and abstinence.
Welin M; Harro J; Yukhananov R; Nyberg F; Oreland L
Neuropeptides; 1994 Jun; 26(6):379-83. PubMed ID: 7936125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
